Deep Dive: Deep Dive Into Cisplatin-Induced Hearing Loss

Oncology Nursing News® meets with the lead investigator of a study which revealed that children under 5 are at the highest risk of hearing loss following treatment with cisplatin chemotherapy. Dr. Bruce Carleton discusses the benefits and risks associated with this life-saving therapy, and the challenge of balancing these risks when treating young children with cancer.